Introduction. To-date, the influence of heavy metals such as Pb or Cd on mental functioning, and especially on the occurrence of depressive and anxiety-related disorders, has not been well understood. Objectives. 1) Assessment of Pb and Cd levels in whole blood of postmenopausal women. 2) Assessment of the severity of anxiety and depressive symptoms depending on Pb and Cd levels in whole blood of postmenopausal women. Materials and method. The survey-based study involved 198 healthy postmenopausal women from West Pomeranian province in Poland. It was performed using the Primary Care Evaluation of Mental Disorders (PRIME-MD), Beck's Depression Inventory (BDI), and the State-Trait Anxiety Inventory (STAI). The second part of the study was based on biochemical analysis of the levels of heavy metals (Pb, Cd). Results. The mean level of Pb was 19.85 ± 8.99 µg/l and Cd 0.87±0.98 µg/l; these levels were within normal ranges. Analysis of the mean levels of Pb and Cd in whole blood of postmenopausal women in relation to the severity of depressive symptoms did not reveal statistically significant differences. Correlation analysis demonstrated a statistically significant (p<0.05) negative correlation (-0.22) between the level of Pb and the severity of anxiety as a state. Correlations between the levels of Pb and Cd and the severity of anxiety as a trait were not statistically significant. Conclusions. The mean Pb and Cd levels in whole blood of healthy postmenopausal women did not exceed acceptable limits. The study did not confirm a relationship between the levels of selected heavy metals and the severity of anxiety and depressive symptoms in healthy women. However, there was a relationship between the level of Pb and the severity of anxiety as a state.
INTRODUCTION
There are many reports indicating a negative influence of environmental pollutants on the human body. However, to-date, the influence of heavy metals such as Pb or Cd on mental functioning, and especially on the occurrence of depressive and anxiety-related disorders has not been well understood [1] ; therefore, the presented research and analysis were undertaken with the aim of assessing the dependence between concentrations of heavy metals (Pb and Cd) in the blood serum, and the severity of depression and anxiety symptoms. The research involved postmenopausal women, due to the particularly high exposure to the occurrence of this type of disorders in people forming this group. Depression is a disorder that mainly concerns females (females are affected 2-3 times more often than males) [2, 3] . In the perimenopausal period, 20-30% of women experience depressive disorders that require treatment, and in 90% it shows weaker mood disorders, i.e.: difficulty in concentrating, irritability and emotional lability as a direct result of hormonal changes [4] . It is also often related to hormonal changes that end the procreative phase, cessation of menstruation, vaginal dryness leading to a decrease in libido, dyspareunia, frequent infections in the genito-urinary tract, urinary incontinence and pelvic organ prolapse. During menopause, a significant increase in hospitalizations for depression can be observed which may be associated with a higher frequency of severe depression [5] .
Anxiety is an interdisciplinary problem characterized by high complexity and multi-dimensionality. It is a negative emotion with an accompanying strong sense of danger and signs of severe psychomotor and autonomous agitation. Single panic attacks are reported by approximately 15% of the general population, whereas the distribution of anxiety disorders with panic attacks occurs in 3-3.5%, on average, and is approximately two to three times more common in women [6] .
Due to the lengthening of life expectancy, as well as demographic processes that cause ageing, women's health problems associated with menopause and ovarian steroid deficiency have become an important public health issue. In the last century, the average age of women's lives exceeded the age of menopause, and currently approximately 30% of a woman's life coincides with the postmenopausal period [7] .
Pb is a highly toxic element with a multivisceral activity. It enters the human body mainly orally through the respiratory system, and to a much lesser extent through the skin [8] . It causes damage of varying severity; from temporary changes to persistent organic ones. Shortly after entering the body it is transported to soft tissues and organs, such as the liver, kidneys, lungs, brain, spleen, muscles and heart. After a few weeks, most of the Pb accumulates in bone tissue. Approximately 94% in adults, and approximately 73% in children of the total Pb contained in the body accumulates in bones and teeth. The time span of its life in soft tissues is about 30 days, and in bones -approximately 40 -90 years. A portion of Pb can be stored in bones for decades, and the remaining portion may leave the reservoir and return to the blood stream or move to other organs in certain specific situations such as pregnancy, lactation, bone fractures or advanced age [9] . Pb can greatly affect the formation of physiological and biochemical disorders. It has been shown that a consequence of occupational exposure to this element is damage to DNA [10] .
Pb has the most damaging effect on the nervous system. If exposure to high doses occurs, Pb can severely damage the brain and kidneys, leading to death [9] .
Cd is a metal toxin that adversely affects the functioning of the human body. It enters the human body orally in 80%, through the respiratory tract in 19% and by contact in 1% [8] . This element induces breaks in the chains of the deoxyribonucleic acid, DNA, and numerous chromosomal aberrations. Numerous organizations involved in public health activities, such as the Environmental Protection Agency (EPA), Department of Health and Human Services (DHHS), and International Agency for Research on Cancer (IARC), identify Cd as a carcinogenic factor to humans [11] . It has been shown that in workers exposed to inhalation of Cd lung cancers were diagnosed more frequently.
In 1999, Cd was recognized by the Agency for Toxic Substances and Disease Registry as one of seven substances found in the environment that have a particularly negative impact on human health [12] . A minimum harmful dosage of Cd which is delivered orally in the medium-long term, i.e. from 15 -364 days, is considered to be an amount of 0.5 mg of Cd/kg/day. The lowest dose for humans which at a shorter time (14 days) would give signs of acute Cd poisoning has yet to be determined. However, long-term exposure to low doses of Cd in inhaled air can cause integration of this metal in the structure of the kidneys which can result in diseases of this organ. As a result of constant exposure to Cd there was also observed a formation of respiratory diseases with dyspnoea, cough, rales, and impaired lung functions [13] . Among the general population, consumption of food and water with a high content of Cd can cause irritation of the stomach, resulting in vomiting or diarrhoea and, in some cases, in death. The consequence of such exposure can be bone fragility, reflected in susceptibility to fractures. Research on laboratory animals have confirmed the dependence between exposure to Cd and occurrence of diseases of the kidneys and bones. It was further found that Cd causes anaemia, liver, brain and nerve damage. In relation to people, there is no clear evidence of the existence of a dependence between elevated Cd and these conditions [14] . 
MATERIALS AND METHOD
The research was conducted among 198 healthy postmenopausal women, residents of the West Pomeranian Province in Poland. Women were selected according to the following criteria: postmenopausal period confirmed by the absence of menstruation for at least a year, no use of the menopausal hormone therapy (MHT), no history of psychiatric treatment, no tumours, no thyroid diseases or diabetes, no addictions (alcohol and cigarettes), correct blood pressure parameters. The first part of the research was carried out using the diagnostic survey method. The study used standardized research tools: -PRIME-MD questionnaire to exclude women with axis I psychiatric disorders according to ICD The second part of the study was biochemical research of the concentration of the toxic metals Pb and Cd.
After obtaining consent to participate in the research, 5 ml of blood was taken from each patient to determine the concentration of Pb and Cd. Blood was collected from the blood vessel in a closed system (Vacutainer) into a tube with an anticoagulant. The biological material was stored at -20 °C. Blood in refrigerated conditions was transported to the Institute of Occupational Medicine and Environmental Health functioning at the Department of Chemical Harmfulness in Sosnowiec, Silesia. Determination of metal toxins was made in the Laboratory of Analysis of Metals. The analytical procedure was based on the method by Stoppler and Brandt. In the blood sample deproteinized with nitric acid the concentration of Pb and Cd in the supernatant fluid was made using atomic absorption spectrometry with electrothermal atomization of a sample (GFAAS). The nonspecific absorption correction included Zeeman's background correction. The measurement was made using atomic absorption spectrometer -Perkin Elmer 4100ZL. Research conducted in this facility is subject to regular quality control through participation in the national and international system of research quality control of the Institute of Occupational Medicine in Łódź, Poland, the Istituto Superiore di Sanita in Rome, Italy, and the CDC in Atlanta, USA. The laboratory has been certified by the German Society of Occupational Medicine and Environmental Medicine e.v., at the FriedrichAlexander University of Erlangen-Nuremberg, Germany.
The maximum admissible concentration of Pb, as interpreted by the Laboratory, was a value of less than 100 mg/l, while the correct value of Cd in whole blood, according to the guidelines of the Institute of Occupational Medicine Environmental Health, was 1.5 mg/l.
The research was approved by the Bioethics Committee [cover for blind review] No. KB-0012/154/12.
Statistical analysis. Pearson's linear correlation coefficient and Spearman's rank correlation coefficient were used to measure the strength of an association between two variables. For the linear correlation between continuous variables which meet the assumption of linear normality. In the case of rank correlation, at least one variable had values presented on the ordinal scale. The results were interpreted using the r/R coefficient and the corresponding probability value (p).
The Student's t-test and Mann-Whitney U test wereused to verify the null hypothesis about the lack of differences concerning quantitative variables between two groups of women. The choice of test depended on confirmation of the normality of the variable distribution.
One-way analysis of variance (ANOVA) was used to verify the following null hypothesis: many groups of women (more than two) are identical in terms of arithmetic means of particular quantitative variables. This was in contradiction of the following alternative hypothesis: statistically significant differences concerning the variables analyzed are observed between at least two groups of women. The results of analysis are shown in the form of F-statistics and p-value. The null hypothesis was rejected in support of the alternative hypothesis if the p-value was below or equal to α.
Characteristics of the study group. The average age of studied women was 56.26±5.55 years; median -55 years; the youngest studied woman was 42-years-old and the oldest was aged 70. More than half of studied women (56%) had secondary education and 32% of patients had higher education. Most women were residents of cities, of which 62% came from cities with population of over 100,000 inhabitants and 23% from smaller towns with a population of 10,000 -100,000 inhabitants. Married women accounted for 69% of patients, those economically active women accounted for 65% of the respondents.
Methods used were descriptive statistics and correlation. Statistical calculations were based on the "Statistica PL" software. During the analysis of Pb and Cd in the context of the level of anxiety and depression in women after menopause, the following statistical methods were used:
RESULTS
Analysis of the average concentrations of Pb and Cd in whole blood depending on severity of depression showed no statistically significant differences. It was shown that the average concentration of Pb in post-menopausal women amounted to 19.85±8.99 µg/l and was within the normal range (below 100 µg/l). The highest concentration of Pb was found in women who experienced severe symptoms of depression (23.70±12.70 µg/l), and the lowest among women with average depression (15.48±5.14 µg/l). The lowest concentration of Cd (0.48±0.28 µg/l) occurred in women who had severe symptoms of depression, and the highest in women who did not show symptoms of depression (0.94±1.11 µg/l). The average concentration of this metal in all postmenopausal women was 0.87±0.98 µg/l and ranged in the widely accepted norms (1.5 µg/l) (Tab. 1).
Analysis of data resulting from the assessment of concentrations of Pb and Cd in postmenopausal women was made taking into account patients in whose self-esteem there were symptoms of depression (n=70) (mild, medium, and heavy), and in whom these symptoms were not diagnosed (n=128). No statistically significant differences (p>0.05) in average concentrations of Pb and Cd in women without symptoms of depression, compared to women who had those symptoms (Tab. 2).
The correlation between severity of depression and the concentration of Pb and Cd in postmenopausal women was not statistically significant (p>0.05) (Tab. 3). Analysis of Pb concentrations in whole blood of postmenopausal women showed statistically significant differences (p<0.01) between the concentration of Pb in the blood of studied women and the intensity of anxiety assessed in the STAI-X1 questionnaire. The highest concentration of Pb in whole blood was obtained in women with no anxiety (22.84±9.79) while the lowest (17.20±7.52) in women who experienced anxiety defined as a condition. There was no such dependence with respect to the concentrations of Cd in whole blood of women surveyed after menopause. The highest concentration of Cd was also demonstrated in women with no anxiety (0.98±0.80), and the lowest (0.73±0.71) in women with anxiety assessed as a condition, but the differences were not statistically significant. Data analysis showed that the highest concentration of Pb in whole blood (21.06±9.56) was found in women with no evidence of anxiety as a characteristic, and the values were higher than those obtained in the whole group of female patients (19.86±8.99). The lowest concentration of this metal (19.14±8.70) was observed in women who experienced anxiety as a characteristic, and this value was similar to the case of women with the anxiety standard (19.61±8.86) (p>0.05). For the concentration of Cd, the highest average level was observed in women with the anxiety standard as a characteristic (0.93±1.20), and the lowest (0.79±0.67) with the anxiety characteristic (p<0.05) (Tab. 4).
Correlation analysis showed a statistically significant (p<0.05) weak negative correlation (-0.22) between the concentration of Pb and intensity of anxiety as a state. The correlation between concentration of Pb and Cd and intensity of anxiety was not statistically significant (Tab. 5).
DISCUSSION
The negative and differential influence of heavy metals on biological functions of the human body has been proven in many studies conducted by scientists worldwide, although the effects that these chemicals may have on the human mental condition are not deeply understood. In the original research, the authors analysed the impact of Pb and Cd concentrations in blood on the severity of depression and anxiety among women in the menopausal age. In the group covered by the analysis there was no dependence between the concentrations of Pb in blood and the level of depression.
Analyses carried out by other authors have pointed to the possibility of a dependence between the concentrations of these heavy metals and risk of developing depressive symptoms. In a study conducted on a group of 5,560 Americans aged 20-80 years, based on data from the US National Health and Nutrition Examination Survey, a dependence between the content of heavy metals in tested urine and the presence of symptoms of depression was observed. The study also showed the influence of other factors from environmental contaminants the greater concentration of which in urine fostered the development of depressive disorders. The findings of this study led to the conclusion that efforts should be made to eliminate harmful chemicals from the human environment, and taken into account in policy planning to ensure the mental health of the population [1] . Similarly, many studies conducted among patients diagnosed with depression and panic attacks showed an excess of Pb and/or Cd [17, 18] . In a study by Eum et al. [19] , an analysis of the concentrations of bone Pb among nurses (mean age 59 years) and its connection with the occurrence of depression and anxiety disorders was made, and it was shown that the increased concentrations of Pb in the tibia in premenopausal women and those after menopause, but using MHT, was associated with a greater severity of depression and anxiety. Simultaneously, those patients showed low concentrations of Pb in blood. A study conducted on a representative group of 2,892 people aged 20-39 showed that there was a dependence between the concentration of Cd in blood and prevalence of depressive symptoms. This relation was not related to smoking. The authors concluded that their findings suggest that limiting the exposure to Cd may affect the reduction in frequency of appearance of depression [20] . Analysis of concentrations of Cd and Pb among 61 adult patients in a psychiatric ward was made at the University Teaching Hospital, comparing their results with a control group. It was shown that the concentrations of Cd and Pb were significantly higher among patients diagnosed with depression, including schizophrenic patients, who showed higher Pb concentrations than subjects in the control group. However, a significantly lower concentration of Cd was found in patients with maniacal disorders [21] . On the other hand, Bouchard et al. investigated a total of 1,987 subjects aged 20-39 who showed higher concentrations of Pb that were associated with a greater severity of depression and panic disorders [22] .
In the original research, analysis of correlation between the intensity of anxiety measured using the STAI-X1 and STAI-X2 surveys, and the concentration of selected microelements in blood of studied postmenopausal women did not show significant differences. However, a significant negative correlation between the concentration of Pb in blood and the intensity of anxiety assessed by the STAI-X1 survey as a state was observed.
It is difficult to comment on the results obtained because the literature shows that the problem of anxiety disorders primarily affects women, increases with age, and it is difficult to decide whether the main reason for disturbances concerns the hormonal changes characteristic of the postmenopausal period, or rather by individual psychosocial and environmental conditions, including the concentration of heavy metals [23] . It is believed that the pre-menopausal period is conducive to intensification of already existing mental imbalances, including anxiety disorders [24] . It should also be taken into account that the surveyed women were healthy, with no mental illnesses, and on the basis of selfassessment one could determine the severity of symptoms of depression and anxiety. Other factors could probably also have affected the level of Pb among the respondents.
CONCLUSIONS
1. The average concentration of Pb and Cd in whole blood of healthy postmenopausal women should not exceed the value adopted as acceptable. 2. Among healthy women, no dependence between concentrations of selected heavy metals and severity of depression and anxiety was observed. 3. The existence was observed of dependence between concentrations of Pb and intensity of anxiety as a state.
